Intervention not reported
Overall adverse effects Duration of trials: 6 to 16 weeks · adults and adolescents with persistent asthma
The intervention showed no clear difference in overall adverse effects Duration of trials: 6 to 16 weeks (moderate certainty).
1 finding from 1 review
- Addition of anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma 2017 · Cochrane Headline outcomes onlyRR 1.06 [0.92, 1.22]3 studies · 1024 participantsModerate